Core Insights - The health care sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - Larimar Therapeutics Inc (NASDAQ:LRMR) has an RSI of 29.9, with shares falling 12.1% to close at $3.12. The company reported a wider-than-expected quarterly loss but highlighted positive long-term data from a clinical study [3][8] - Perrigo Company PLC (NYSE:PRGO) also has an RSI of 29.9, with shares declining 1.7% to close at $13.61. The company reported mixed third-quarter results and lowered its FY25 adjusted EPS guidance, despite gaining market share in several categories [4][8] - ORIC Pharmaceuticals Inc (NASDAQ:ORIC) has an RSI of 29.6, with shares dropping 4.5% to close at $10.65. The company has seen a 16% decline in stock price over the past month [5][8]

Core Viewpoint - Rosen Law Firm is urging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period from February 27, 2023, to November 4, 2025 [1]. Group 1: Legal Action Details - Investors who purchased Perrigo securities during the class period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 16, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from significant underinvestment and required substantial capital expenditures [5]. - It is claimed that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow [5]. - The lawsuit asserts that the positive statements made by Perrigo about its business operations were materially misleading and lacked a reasonable basis, resulting in investor damages when the true details became public [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. - The lead plaintiff must file a motion with the court by January 16, 2026, to represent other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment and required substantial capital expenditures [4]. - It is claimed that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results [4]. - The lawsuit asserts that the positive statements made by Perrigo about its business operations were materially misleading and lacked a reasonable basis, resulting in investor damages when the true details emerged [4].

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Perrigo made false statements and concealed significant issues regarding its infant formula business acquired from Nestlé, including underinvestment in maintenance and operational improvements [3]. - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated estimates to address deficiencies in the infant formula business [3]. - The complaint highlights significant manufacturing deficiencies in the facility related to the infant formula business, leading to overstated financial results, including earnings and cash flow [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [5]. - The firm is recognized as one of the top securities litigation firms in the United States, ranking in ISS Securities Class Action Services' Top 50 Report for seven consecutive years [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the securities class action is from February 27, 2023, to November 4, 2025 [2]. - Investors who purchased Perrigo securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by January 16, 2026 [4]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [5]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including underinvestment in maintenance and significant manufacturing deficiencies [6]. - It is claimed that Perrigo's financial results were overstated due to these issues, leading to misleading positive statements about the company's operations and prospects [6].

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's acquisition of the infant formula business from Nestlé was significantly underinvested in maintenance and operational improvements [2]. - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2]. - The complaint points out significant manufacturing deficiencies in the facility dedicated to the infant formula business [2]. - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were reportedly overstated [2]. - The positive statements made by the defendants regarding the Company's business and prospects were claimed to be materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Perrigo Company plc regarding a class action lawsuit due to alleged misleading statements and operational deficiencies related to the company's infant formula business [2][4]. Summary by Relevant Sections Allegations - The complaint alleges that during the class period from February 27, 2023, to November 4, 2025, Perrigo made materially false and misleading statements and failed to disclose significant issues, including: 1. The infant formula business acquired from Nestlé suffered from underinvestment in maintenance and operational improvements [2]. 2. Perrigo needed to incur substantial capital and operational expenditures beyond previously stated estimates to remediate the infant formula business [2]. 3. There were significant manufacturing deficiencies in the facility for the infant formula business [2]. 4. As a result, the company's financial results, including earnings and cash flow, were overstated [2]. 5. The positive statements made by defendants regarding the company's business and prospects were materially misleading and lacked a reasonable basis [2]. Next Steps for Shareholders - Shareholders who purchased shares of PRGO during the specified timeframe are encouraged to register for the class action by January 16, 2026, to potentially be appointed as lead plaintiff [3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case [3]. Law Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights and ensuring companies adhere to responsible business practices [4].

Core Insights - Meridian Contrarian Fund reported a 6.72% net return in Q3 2025, underperforming the Russell 2500 Index which returned 9.00% and the Russell 2500 Value Index at 8.18% [1] - The fund's performance was influenced by record high equities, driven by technology gains and falling bond yields, alongside easing tariff rhetoric and renewed AI infrastructure investments [1] Company Analysis: Perrigo Company plc (NYSE:PRGO) - Perrigo Company plc is a leading provider of over-the-counter health and wellness solutions, but its stock has faced significant declines, with a one-month return of -34.97% and a 52-week loss of 53.13% [2] - As of November 28, 2025, Perrigo's stock closed at $13.35, with a market capitalization of $1.837 billion [2] - The company has struggled with declining earnings due to poor capital allocation by previous management, which focused on acquisitions outside its core business [3] - A new management team is now focused on realistic growth within the core business, aiming for improved profitability and returns on capital [3] - Despite recent underperformance, the company continues to be held in the fund's portfolio, although earnings guidance has been lowered due to challenges in the recovering infant formula business [3] Investment Sentiment - Perrigo Company plc is not among the 30 most popular stocks among hedge funds, with 22 hedge fund portfolios holding the stock at the end of Q3 2025, unchanged from the previous quarter [4] - While acknowledging Perrigo's potential, the fund suggests that certain AI stocks may offer greater upside potential and less downside risk [4]

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its infant formula business acquired from Nestlé [1][3]. Group 1: Class Action Details - The class action lawsuit is titled French v. Perrigo Company plc and covers securities purchases made between February 27, 2023, and November 4, 2025, with a deadline for lead plaintiff applications set for January 16, 2026 [1][8]. - The lawsuit alleges that Perrigo's acquisition of Nestlé's Gateway infant formula plant for $170 million was marred by significant underinvestment and operational deficiencies [2][3]. Group 2: Financial Implications - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation efforts, alongside a 50% decline in earnings per share compared to the previous year, leading to a stock price drop of over 15% [4]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, resulting in a nearly 10% drop in stock price [5]. - On August 6, 2025, Perrigo's adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing an over 11% decline in stock price [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, slashing its fiscal year 2025 outlook, which included a negative sales growth guidance of -2.5% to -3% and a significant cut in expected earnings per share, leading to a stock price drop of over 25% [7].

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for alleged violations of securities laws, specifically related to misleading statements made after its acquisition of Nestlé's baby formula business [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from February 27, 2025, to November 4, 2025, with a deadline for lead plaintiff appointments set for January 16, 2026 [2]. - The complaint alleges that Perrigo made false and misleading statements regarding the condition of the acquired business, which required significant investments for maintenance and repairs [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although this is not necessary to participate in any recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress at no cost [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4].